ARCH Venture Fund VIII Overage, L.P.'s Net Worth

$525 Million

Estimate Recalculated Feb 16, 2024 04:32PM EST

Who is ARCH Venture Fund VIII Overage, L.P.?

ARCH Venture Fund VIII Overage, L.P. has an estimated net worth of $525 Million. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Quanterix Corp, Twist Bioscience Corp, Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..

SEC CIK

ARCH Venture Fund VIII Overage, L.P.'s CIK is 0001617237

Past Insider Trading and Trends

2020 was ARCH Venture Fund VIII Overage, L.P.'s most active year for acquiring shares with 16 total transactions. ARCH Venture Fund VIII Overage, L.P.'s most active month to acquire stocks was the month of August. 2020 was ARCH Venture Fund VIII Overage, L.P.'s most active year for disposing of shares, totalling 13 transactions. ARCH Venture Fund VIII Overage, L.P.'s most active month to dispose stocks was the month of August. 2023 saw ARCH Venture Fund VIII Overage, L.P. paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2020 ARCH Venture Fund VIII Overage, L.P. cashed out on 30,643,367 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Metacrine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.94M
$13.00
2.94M
Sep 18
Form 3
0
0
No matching records found

Unity Biotechnology, Inc. (UBX) Snapshot price: $1.7389

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25,308.20%
10.01M
10.05M
May 7
Form 3
0
0
No matching records found

Codiak BioSciences, Inc. (CDAKQ) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+129.73%
5M
$1.50
$7,500,000.00
8.85M
Sep 13
Form 4
+75.61%
3.79M
$15.00
$3,525,000.00
8.8M
Oct 16
Form 3
0
0
No matching records found

Sienna Biopharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+59.61%
2.17M
$2.50
$5,414,500.00
5.8M
Feb 22
Form 4
3.63M
3.63M
Aug 1
Form 3
0
0
No matching records found

Homology Medicines, Inc. (FIXX) Snapshot price: $0.715

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.94%
-300.00K
5.77M
May 21
Form 4
6.07M
6.07M
Apr 2
Form 3
0
0
No matching records found